376
Participants
Start Date
February 19, 2018
Primary Completion Date
May 22, 2019
Study Completion Date
May 30, 2020
Sotagliflozin
Pharmaceutical form: Tablet; Route of administration: Oral
Placebo
Pharmaceutical form: Tablet; Route of administration: Oral
Investigational Site Number 1589004, Taipei
Investigational Site Number 1589008, New Taipei City
Investigational Site Number 1589006, Taichung
Investigational Site Number 1589005, Changhua
Investigational Site Number 1589001, Tainan City
Investigational Site Number 5549004, Auckland
Investigational Site Number 4109001, Seoul
Investigational Site Number 0369002, Merewether
Investigational Site Number 5549001, Rotorua
Investigational Site Number 0369004, Parkville
Investigational Site Number 5549002, Wellington
Investigational Site Number 0369003, Fremantle
Investigational Site Number 5549003, Christchurch
Investigational Site Number 1589003, Taipei
Investigational Site Number 4109005, Guri-Si, Gyeonggi-Do
Investigational Site Number 4109003, Gyeonggi-do
Investigational Site Number 4849001, Aguascalientes
Investigational Site Number 4849006, Aguascalientes, Aguascalientes
Investigational Site Number 8409002, Chapel Hill
Investigational Site Number 8409012, Columbus
Investigational Site Number 4109006, Daejeon
Investigational Site Number 8409004, Chattanooga
Investigational Site Number 1589007, Taichung
Investigational Site Number 4849002, Guadalajara Jalisco
Investigational Site Number 4849003, Cuernavaca
Investigational Site Number 4849004, Monterrey
Investigational Site Number 8409003, Dallas
Investigational Site Number 8409007, Katy
Investigational Site Number 8409013, Austin
Investigational Site Number 8409015, Albuquerque
Investigational Site Number 4849005, Xalapa
Investigational Site Number 8409009, Escondido
Investigational Site Number 8409005, Walnut Creek
Investigational Site Number 8409010, Greenbrae
Investigational Site Number 6439006, Yaroslavl
Investigational Site Number 6439001, Saint Petersburg
Investigational Site Number 6439002, Saint Petersburg
Investigational Site Number 6439003, Saint Petersburg
Investigational Site Number 6439005, Novosibirsk
Investigational Site Number 6439007, Kemerovo
Investigational Site Number 8409011, Evansville
Investigational Site Number 8409014, Wichita
Investigational Site Number 8409001, Wilmington
Investigational Site Number 8409008, Dayton
Investigational Site Number 1249003, Brampton
Investigational Site Number 1249008, Etobicoke
Investigational Site Number 1249005, Pointe-Claire
Investigational Site Number 1249006, Thornhill
Investigational Site Number 1249004, Thornhill
Investigational Site Number 1249007, Vancouver
Investigational Site Number 1249002, Victoriaville
Investigational Site Number 4109004, Seoul
Investigational Site Number 1589002, Tainan City
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Lexicon Pharmaceuticals
INDUSTRY